Avai Bio (AVAI) Current Deferred Tax Assets (2018 - 2020)

Avai Bio has disclosed Current Deferred Tax Assets across 3 years of filings, most recently posting -$14078.0 for Q1 2020.

• In Q1 2020, Current Deferred Tax Assets rose 15.1% year-over-year to -$14078.0; the TTM figure through Mar 2020 stood at -$14078.0 (up 15.1% YoY), while the FY2020 annual figure was -$14078.0, up 15.1% from the prior year.
• Current Deferred Tax Assets came in at -$14078.0 for Q1 2020 at Avai Bio, up from -$16582.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of -$155.0 in Q1 2018 to a low of -$16582.0 in Q1 2019.
• Average Current Deferred Tax Assets over 3 years is -$8029.2, with a median of -$7689.8 recorded in 2020.
• Year-over-year, Current Deferred Tax Assets tumbled 10598.06% in 2019 and rose 15.1% in 2020.
• Over 3 years, Current Deferred Tax Assets stood at -$1301.6 in 2018, then slumped by 1173.96% to -$16582.0 in 2019, then gained by 15.1% to -$14078.0 in 2020.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were -$14078.0 in Q1 2020, -$16582.0 in Q1 2019, and -$1301.6 in Q2 2018.